SUPN logo

Supernus Pharmaceuticals (SUPN) Return On Assets

Annual ROA

0.09%
-3.49%-97.49%

December 31, 2023

Summary

Performance

1-Year Change

-97.49%

3-Year Change

-99.06%

5-Year Change

-99.43%

15-Year Change

-99.42%

SUPN ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.99%
SUPN annual return on assets is higher than 83.99% of companies in Healthcare sector

High & Low

All-time High

106.84%
SUPN annual return on assets is currently -99.92% below its historical high of 106.84%

3-Year Low

0.09%
SUPN annual return on assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SUPN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 27, 2025
SUPN next annual earnings announcement is scheduled for Feb 27, 2025

OtherSUPNprofitabilitymetrics:

Annual Revenue

$607.52 M
SUPN annual revenue is $607.52 million

Annual Net Income

$1.32 M
SUPN annual net profit is $1.32 million

Annual EPS

$0.02
SUPN annual earnings per share is $0.02

Annual ROE

0.15%
SUPN annual return on equity is 0.15%

Quarterly ROA

4.58%
+4.18%+1045.00%

September 30, 2024

Summary

Performance

3-Month Change

+1045%

1-Year Change

+177.58%

3-Year Change

+177.58%

5-Year Change

+177.58%

SUPN Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.01%
SUPN quarterly return on assets is higher than 89.01% of companies in Healthcare sector

High & Low

All-time High

129.04%
SUPN quarterly return on assets is currently -96.45% below its historical high of 129.04%

3-Year Low

-1.12%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SUPN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
SUPN next earnings announcement is scheduled for Feb 27, 2025

OtherSUPNprofitabilitymetrics:

Quarterly Revenue

$175.69 M
SUPN quarterly revenue is $175.69 million

Quarterly Net Income

$38.50 M
SUPN quarterly net profit is $38.50 million

Quarterly EPS

$0.69
SUPN quarterly earnings per share is $0.69

Quarterly ROE

6.32%
SUPN quarterly return on equity is 6.32%

ROA Formula

ROA =  Net Income
Total Assets ✕ 100%

Annual ROA

0.09%
SUPN annual return on assets is 0.09%

Annual Net Income

$1.32 M
SUPN annual net profit is $1.32 million

Annual Total Assets

$1.28 B
SUPN annual total assets is $1.28 billion

SUPN ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-97.5%+177.6%
3 y3 years-99.1%+177.6%
5 y5 years-99.4%+177.6%

SUPN ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-97.5%at low-0.4%+508.9%
5 y5-year-99.2%at low-56.8%+508.9%
alltimeall time-99.9%+100.1%-96.5%+105.4%

Supernus Pharmaceuticals ROA History

DateAnnualQuarterly
Sep 2024
-
4.58%(+1045.0%)
Jun 2024
-
0.40%(-135.7%)
Mar 2024
-
-1.12%(-1344.4%)
Dec 2023
0.09%(-97.5%)
0.09%(-94.5%)
Sep 2023
-
1.65%(-37.7%)
Jun 2023
-
2.65%(-13.1%)
Mar 2023
-
3.05%(-15.5%)
Dec 2022
3.58%(+6.9%)
3.61%(+58.3%)
Sep 2022
-
2.28%(-35.4%)
Jun 2022
-
3.53%(-23.3%)
Mar 2022
-
4.60%(+34.9%)
Dec 2021
3.35%(-64.8%)
3.41%(-36.1%)
Sep 2021
-
5.34%(-19.1%)
Jun 2021
-
6.60%(-14.4%)
Mar 2021
-
7.71%(-16.7%)
Dec 2020
9.53%(-9.9%)
9.26%(-7.5%)
Sep 2020
-
10.01%(+1.8%)
Jun 2020
-
9.83%(-6.2%)
Mar 2020
-
10.48%(-1.1%)
Dec 2019
10.58%(-33.2%)
10.60%(+2.1%)
Sep 2019
-
10.38%(-4.2%)
Jun 2019
-
10.84%(-3.0%)
Mar 2019
-
11.18%(-19.3%)
Dec 2018
15.83%(+1.4%)
13.86%(-4.3%)
Sep 2018
-
14.48%(-5.4%)
Jun 2018
-
15.30%(-3.9%)
Mar 2018
-
15.92%(-0.6%)
Dec 2017
15.61%
16.02%(-8.8%)
Sep 2017
-
17.57%(-49.8%)
DateAnnualQuarterly
Jun 2017
-
35.03%(-3.6%)
Mar 2017
-
36.35%(-4.6%)
Dec 2016
36.62%(+327.3%)
38.12%(-4.1%)
Sep 2016
-
39.75%(+183.7%)
Jun 2016
-
14.01%(+31.1%)
Mar 2016
-
10.69%(+20.5%)
Dec 2015
8.57%(-197.2%)
8.87%(+18.0%)
Sep 2015
-
7.52%(+113.0%)
Jun 2015
-
3.53%(-21.7%)
Mar 2015
-
4.51%(-146.7%)
Dec 2014
-8.82%(-90.2%)
-9.65%(-71.3%)
Sep 2014
-
-33.57%(-36.3%)
Jun 2014
-
-52.68%(-36.0%)
Mar 2014
-
-82.27%(-3.7%)
Dec 2013
-90.03%(+43.7%)
-85.47%(+1.6%)
Sep 2013
-
-84.09%(+4.5%)
Jun 2013
-
-80.49%(+5.5%)
Mar 2013
-
-76.29%(+11.4%)
Dec 2012
-62.66%(-158.6%)
-68.49%(-176.9%)
Sep 2012
-
89.07%(-12.0%)
Jun 2012
-
101.25%(-21.5%)
Mar 2012
-
129.04%(+6.3%)
Dec 2011
106.84%(-276.2%)
121.35%(-275.3%)
Sep 2011
-
-69.22%(+34.0%)
Jun 2011
-
-51.67%(+37.6%)
Mar 2011
-
-37.55%(+128.8%)
Dec 2010
-60.62%(<-9900.0%)
-16.41%(+37.7%)
Sep 2010
-
-11.92%(+16.3%)
Dec 2009
0.59%(-101.4%)
-10.25%
Dec 2008
-43.41%
-

FAQ

  • What is Supernus Pharmaceuticals annual return on assets?
  • What is the all time high annual ROA for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual ROA year-on-year change?
  • What is Supernus Pharmaceuticals quarterly return on assets?
  • What is the all time high quarterly ROA for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly ROA year-on-year change?

What is Supernus Pharmaceuticals annual return on assets?

The current annual ROA of SUPN is 0.09%

What is the all time high annual ROA for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual return on assets is 106.84%

What is Supernus Pharmaceuticals annual ROA year-on-year change?

Over the past year, SUPN annual return on assets has changed by -3.49% (-97.49%)

What is Supernus Pharmaceuticals quarterly return on assets?

The current quarterly ROA of SUPN is 4.58%

What is the all time high quarterly ROA for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly return on assets is 129.04%

What is Supernus Pharmaceuticals quarterly ROA year-on-year change?

Over the past year, SUPN quarterly return on assets has changed by +2.93% (+177.58%)